Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?

dc.contributor.author	Sabrià, Enric
dc.contributor.author	Lequerica Fernández, Paloma
dc.contributor.author	Lafuente Ganuza, Paula
dc.contributor.author	Edwin Eguia, Ángeles
dc.contributor.author	Escudero Gomis, Ana Isabel
dc.contributor.author	Martínez Morillo, Eduardo
dc.contributor.author	Álvarez Menéndez, Francisco Vicente
dc.date.accessioned	2018-02-28T10:41:39Z
dc.date.available	2018-02-28T10:41:39Z
dc.date.issued	2017
dc.identifier.citation	Clinical Chemistry and Laboratory Medicine, 56(2), (2017); doi:10.1515/cclm-2017-0443
dc.identifier.issn	1434-6621
dc.identifier.uri	http://hdl.handle.net/10651/46378
dc.language.iso	eng
dc.relation.ispartof	Clinical Chemistry and Laboratory Medicine
dc.rights	©,
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85037615111&doi=10.1515%2fcclm-2017-0443&partnerID=40&md5=9d658ddbe314c5f47344fd2b635a44a3
dc.title	Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
dc.type	journal article
dc.identifier.doi	10.1515/cclm-2017-0443
dc.relation.publisherversion	http://dx.doi.org/10.1515/cclm-2017-0443

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.